Combi-seq: a leap forward for personalised cancer therapy
Science Researchers have come up with a way to test the efficacy of hundreds of anticancer drug combinations – simultaneously, rapidly, and accurately.
2022
science
An ocean of droplets
Picture of the week Bacterial cells are embedded in microfluidic droplets in oil. The fluorescence indicates the presence of the targeted DNA strain with the help of a characteristic DNA sequence.
2020
picture-of-the-week
The hunt for neutralising antibodies against SARS-CoV-2
Science Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat others. The Merten group at EMBL Heidelberg has pivoted its microfluidics platform to support the search for neutralising antibodies that could…
2020
science
Miniature testing of drug pairs on tumour biopsies
Science Combinations of cancer drugs can be quickly and cheaply tested using a novel microfluidic device
2018
science
EMBL spinoff to help antibody discovery
Lab Matters New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
2018
lab-matters
Sorting out HIV
Science An EMBL collaboration devises a new method that could speed up vaccine development for HIV
2017
science
First, find your membrane
Science Collaboration between scientists reveals collaboration between lipids.
2015
science
Sense of space
Science EMBL scientists demonstrate that spatial constraints are a key factor in determining nucleus size.
2015
science
No matching posts found
